网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
高龄冠心病合并糖尿病患者冠脉介入治疗的临床观察
作者:于洁 冯毅 马根山 
单位:东南大学医学院
关键词:高龄 经皮冠状动脉介入治疗 冠心病合并2型糖尿病 
分类号:
出版年·卷·期(页码):2012·31·第六期(671-674)
摘要:

目的:探讨高龄冠心病合并2型糖尿病患者行PCI的安全性及临床疗效。方法:回顾分析我院高龄冠心病合并2型糖尿病患者(65例)和非糖尿病患者(70例)行PCI的临床及冠脉病变特点、手术成功率和主要不良心脏事件(MACE)。结果:糖尿病组冠脉三支病变、复杂病变明显高于非糖尿病组(35.4%比18.6%;69.2%比51.4%,P﹤0.05);PCI成功率及住院期间MACE发生率两组间差异无统计学意义。随访9~24个月,糖尿病组心绞痛复发、再次血运重建率均高于非糖尿病组(分别为14.1%比8.7%;12.5%比2.90%,P﹤0.05);心性死亡、非致死性心梗、再狭窄发生率两组间差异无统计学意义,两组均无迟发性支架内血栓发生。结论:对75岁以上冠心病合并2型糖尿病患者行PCI治疗是安全有效的

Objective: To evaluate the safety and clinical efficiency of percutaneous coronary intervention (PCI) in elderly patients with coronary heart disease and type 2 diabetes mellitus. Methods: 65 elderly patients with coronary heart disease and type 2 diabetes mellitus who underwent percutaneous coronary intervention were compared with 70 patients without diabetes mellitus in lesion characteristics of coronary artery, successful rates and major adverse cardiac events(MACE). Result:Triple vessel disease and complex lesions were higher in the diabetics group than those in the non-diabetics group (35.4% vs 18.6%; 69.2% vs 51.4%,P﹤0.05). The success rate of PCI and the rate of MACE during the hospitalization period were found no difference. The follow-up period for all the patients was in the range of 9 to 24 months. The rate of re-angina and target vessel revascularization were higher in the diabetics group than those in the non-diabetics group (14.1% vs 8.7%; 12.5% vs 2.90%, P﹤0.05). Cardiac deaths, nonfatal myocardial infarction, the incidence of restenosis were found no difference. Late acute stent thrombosis did not occur in both groups. Conclusion: In elderly patients with coronary heart disease and diabetes mellitus, PCI was a safe and effective procedure.

参考文献:
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 758647 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541